Key facts
- It has raised $71.8M; the latest was Accelerator/Incubator in Jun 2025.
- Notable investors include MedTech Innovator, Participatiemaatschappij Vlaanderen, Sensinnovat, Ackermans & van Haaren, Capricorn Partners — 17 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 17 names
- ·Watchlist + deal alerts for Indigo (Monitoring Equipment)
- ·The full record, as it builds
Funding rounds
No funding rounds for Indigo (Monitoring Equipment) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Indigo (Monitoring Equipment)
Developer of needle-free glucose sensors designed to address the need for accurate and low-cost chronic disease monitoring systems. The company's sensors exploit a groundbreaking photonics technology that helps to monitor glucose in the body, enabling patients to keep track of their diabetes levels.
- Sector
- Healthcare
- HQ
- Gent, Belgium
- Founded
- 2016
- Employees
- 33
- Website
- indigomed.com/
- Ownership
- Privately Held (backing)
Indigo (Monitoring Equipment) doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Indigo (Monitoring Equipment) shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Indigo (Monitoring Equipment) in its N-PORT filings yet. We sweep new filings monthly.